Abuse-deterrent single-entity hydrocodone products are edging closer to market. Purdue Pharma LP has announced that the US Food and Drug Administration (FD) has granted Priority Review designation for ...

SAN ANTONIO — As an abuse-deterrent version of hydrocodone extended-release (ER) moves closer to market, the company developing the product (Vantrela ER, Teva Pharmaceutical Industries) has released ...

SAN DIEGO, July 2, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX) today announced an update on its development programs focused on the introduction of abuse deterrent formulations of Zohydro(R) ER ...

ST. LOUIS Covidien has released a cough suppressant that lasts up to 12 hours, the company has announced. The company describes TussiCaps as the first and only hydrocodone antitussive oral capsules ...

Pernix announced the launch of a new formulation of Zohydro ER (hydrocodone bitartrate extended-release capsules) with BeadTek, a new abuse-deterrent technology. The new formulation included BeadTek, ...

With the nation and Long Island in the grip of an epidemic of prescription painkiller abuse, it's a bewildering mistake to make the narcotic hydrocodone legally available in a pure form so ripe for ...

New Zohdryo ER Formulation sNDA Submitted to FDA Zogenix announced the submission of a supplemental New Drug Application (sNDA) to the Food and Drug Administration (FDA) for a modified formulation of ...

The U.S. Food and Drug Administration today approved Zohydro ER (hydrocodone bitartrate extended-release capsules) for the management of pain severe enough to require daily, around-the-clock, ...

Teva Pharmaceutical Industries Ltd.’s hydrocodone painkiller works to deter people who might try to crush the drug and snort or inject it to get high, U.S. regulators said. The extended-release ...